Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chloramphenicol: properties and clinical use

C I Laferriere, M I Marks

    Pediatric Infectious Disease
    |July 1, 1982
    PubMed
    Summary

    Chloramphenicol inhibits protein synthesis in bacteria and mitochondria. Understanding its role in aplastic anemia is key to expanding its use in treating severe infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oral therapy for orthopedic infections in children and adults.

    Orthopedics·2014
    Same author

    URIs in children.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Smallpox vaccination.

    Canadian Medical Association journal·2010
    Same author

    Adverse reactions to 1975 bivalent influenza vaccine in children.

    Canadian Medical Association journal·2010
    Same author

    Respiratory syncytial virus infection in isolated populations.

    The Pediatric infectious disease journal·1995
    Same author

    Infectious diarrhea: introduction and commentary.

    Pediatric annals·1994

    Area of Science:

    • Pharmacology
    • Microbiology
    • Toxicology

    Background:

    • Chloramphenicol, introduced in 1949, inhibits bacterial and mitochondrial protein synthesis.
    • Adverse effects like bone marrow suppression and gray baby syndrome are linked to its mechanism.
    • The pathogenesis of chloramphenicol-induced aplastic anemia is not fully understood.

    Purpose of the Study:

    • To review the clinical applications and adverse effects of chloramphenicol.
    • To highlight the need for understanding chloramphenicol-induced aplastic anemia.

    Main Methods:

    • Literature review of chloramphenicol's pharmacology, toxicology, and clinical use.
    • Analysis of its mechanism of action on protein synthesis and cellular metabolism.

    Main Results:

    • Chloramphenicol exhibits broad-spectrum activity but has dose-dependent effects on cellular metabolism.
    • Interindividual variations in metabolism and elimination are significant, especially in neonates.
    • Established indications include invasive H. influenzae, meningitis, Rocky Mountain spotted fever, and severe anaerobic infections.

    Conclusions:

    • Elucidating the pathogenesis of aplastic anemia is crucial for optimizing chloramphenicol's therapeutic applications.
    • Chloramphenicol remains a valuable agent for specific severe infections where alternatives are limited.

    Related Experiment Videos